The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 24, 2026
Filed:
Apr. 16, 2020
Applicants:
Hiroshima University, Hiroshima, JP;
Tokyo Women's Medical University, Tokyo, JP;
Chugai Seiyaku Kabushiki Kaisha, Tokyo, JP;
Inventors:
Hiroaki Honda, Tokyo, JP;
Kohei Kobatake, Hiroshima, JP;
Assignees:
Tokyo Women's Medical University, Tokyo, JP;
Hiroshima University, Hiroshima, JP;
Chugai Seiyaku Kabushiki Kaisha, Tokyo, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/24 (2006.01); A61K 31/28 (2006.01); A61K 31/80 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61P 13/00 (2006.01); A61P 13/10 (2006.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01); A61P 13/08 (2006.01); A61P 13/12 (2006.01);
U.S. Cl.
CPC ...
C07K 16/248 (2013.01); A61K 31/80 (2013.01); A61K 39/3955 (2013.01); A61P 35/00 (2018.01); C07K 16/24 (2013.01); C07K 16/2866 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01);
Abstract
Therapeutic agents and treatment methods for urologic cancers, particularly urologic cancers with reduced lysine (K)-specific demethylase 6A (KDM6A) function, the agents and methods being characterized by suppressing both IL-6 activity and CCR2/CCL2 activity, are provided.